Equities

Proteome Sciences PLC

PRM:LSE

Proteome Sciences PLC

Health CarePharmaceuticals and Biotechnology
  • Price (GBX)1.77
  • Today's Change0.015 / 0.85%
  • Shares traded504.75k
  • 1 Year change-58.25%
  • Beta0.7833
Data delayed at least 20 minutes, as of Feb 06 2026 16:29 GMT.
More ▼

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of GBP
(except for per share items)
Fiscal data as of Dec 31 2024202420232022
ASSETS
Cash And Short Term Investments1.132.033.99
Total Receivables, Net0.591.131.74
Total Inventory0.730.840.90
Prepaid expenses0.140.170.26
Other current assets, total0.00----
Total current assets2.594.166.90
Property, plant & equipment, net2.403.081.32
Goodwill, net4.224.224.22
Intangibles, net------
Long term investments------
Note receivable - long term------
Other long term assets------
Total assets9.211112
LIABILITIES
Accounts payable------
Accrued expenses0.140.180.15
Notes payable/short-term debt01111
Current portion long-term debt/capital leases130.610.30
Other current liabilities, total0.640.450.78
Total current liabilities141212
Total long term debt1.291.630.35
Total debt151312
Deferred income tax------
Minority interest------
Other liabilities, total0.420.420.43
Total liabilities161513
SHAREHOLDERS EQUITY
Common stock2.952.952.95
Additional paid-in capital515151
Retained earnings (accumulated deficit)(61)(57)(55)
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total(0.09)(0.01)0.03
Total equity(6.52)(3.07)(0.84)
Total liabilities & shareholders' equity9.211112
Total common shares outstanding295295295
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on InvestorsChronicle.co.uk is subject to the Investors Chronicle Terms & Condition
All content on InvestorsChronicle.co.uk is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by IC and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via Investors Chronicle is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. Investors Chronicle is not responsible for any use of content by you outside its scope as stated in the Investors Chronicle Terms & Condition.